lung cancer, malignant mesothelioma
Conditions
Interventions
Effecacy and the safety when switching from the tramadol to fentanyl sticking medcine in the third where the conversion chart based on 500:1 compared with general conversion is used in foreign countri
Sponsors
Osaka Prefectural Medical Center for Respiratory and Allergic Diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1:Patient who has cancer pain in lung cancer and malignant pleura mesothelioma from which tramadol hydrochloric acid salt capsule in the following less than 300mg/day is administered 2:It is NRS(Numeric Rating Scale) in 11 stages (0-10) and it is a patient of five or less.
Exclusion criteria
Exclusion criteria: Patient who has hypersensitivity for opioid Patient who has previous history of opioid abuse Patient who has breath function trouble of chronic lung disorders etc. Defective asthmatic patient to control Patient who has serious depressed ventricular function Patient who has serious liver and renal dysfunction Patient who has increased intracranial pressure and impaired consciousness Patient who has skin disorder such as eczema and atopy in experimental drug sticking part Patient where generation of heat of 40 degree or more is admitted Patient who has pregnant woman, breast-feeding woman or possibility of pregnancy Patient who has scheduled patient or administering that administers pentazocine and Pius id receptor rivalry medicine of buprenorphine etc. within two days before it sticks it (The patient who executes the bronchoscope treatment excludes it). Patient whose age is less than 18 years old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Effecacy (2)Safety (3)Patient satisfaction | — |
Countries
Japan
Contacts
Public ContactMotohiro Tamiya
Osaka Prefectural Medical Center for Respiratory and Allergic Diseases Thoracic Malignancy
Outcome results
None listed